Acadian Asset Management’s China SXT Pharmaceuticals SXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 1827 |
|
|
2025
Q1 | $0 | Buy |
48
+1
| +2% | – | ﹤0.01% | 1808 |
|
|
2024
Q4 | $0 | Hold |
47
| – | – | ﹤0.01% | 2146 |
|
|
2024
Q3 | $0 | Sell |
47
-298
| -86% | – | ﹤0.01% | 2326 |
|
|
2024
Q2 | $2K | Hold |
345
| – | – | ﹤0.01% | 1723 |
|
|
2024
Q1 | $3K | Hold |
345
| – | – | ﹤0.01% | 1536 |
|
|
2023
Q4 | $10K | Sell |
345
-180
| -34% | -$5.22K | ﹤0.01% | 1624 |
|
|
2023
Q3 | $12K | Hold |
525
| – | – | ﹤0.01% | 1586 |
|
|
2023
Q2 | $23K | Hold |
525
| – | – | ﹤0.01% | 1636 |
|
|
2023
Q1 | $28K | Buy |
525
+297
| +130% | +$15.8K | ﹤0.01% | 1603 |
|
|
2022
Q4 | $24K | Buy |
+228
| New | +$24K | ﹤0.01% | 1696 |
|
|
2022
Q2 | – | Sell |
-28
| Closed | -$31K | – | 1851 |
|
|
2022
Q1 | $31K | Buy |
+28
| New | +$31K | ﹤0.01% | 1520 |
|
|
2020
Q4 | – | Sell |
-4
| Closed | -$14K | – | 2351 |
|
|
2020
Q3 | $14K | Sell |
4
-59
| -94% | -$207K | ﹤0.01% | 2107 |
|
|
2020
Q2 | $531K | Buy |
63
+62
| +6,200% | +$523K | ﹤0.01% | 1170 |
|
|
2020
Q1 | $10K | Buy |
+1
| New | +$10K | ﹤0.01% | 1707 |
|